DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Next Generation Sequencers - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Next Generation Sequencers in US$ Thousand. The Global market is additionally analyzed by the following End-Use Segments: Pharmaceutical/Biotech, Industrial, and Government/Academia. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
Company profiles are primarily based on public domain information including company URLs. The report profiles 93 companies including many key and niche players such as:
- Agilent Technologies Inc. (US)
- Becton, Dickinson and Company (BD) (US)
- Fluidigm Corporation (US)
- Genomatix GmbH (Germany)
- Illumina, Inc. (US)
- Oxford Gene Technology (UK)
- Oxford Nanopore Technologies (UK)
- Pacific Biosciences of California, Inc. (US)
- QIAGEN N.V. (The Netherlands)
- RainDance Technologies, Inc. (US)
- Roche Sequencing (US)
- Shenzhen BGI Diagnosis Co., Ltd. (China)
- Thermo Fisher Scientific, Inc. (US)
Key Topics Covered:
1. OVERVIEW
2. COMPETITIVE LANDSCAPE
3. GROWTH DRIVERS, MARKET TRENDS & ISSUES
4. TECHNOLOGY OVERVIEW
5. PRODUCT INNOVATIONS/INTRODUCTIONS
6. RECENT INDUSTRY ACTIVITY
7. FOCUS ON SELECT GLOBAL PLAYERS
8. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 93 (including Divisions/Subsidiaries - 104)
- The United States (61)
- Canada (3)
- Japan (2)
- Europe (27)
- France (1)
- Germany (7)
- The United Kingdom (5)
- Rest of Europe (14)
- Asia-Pacific (Excluding Japan) (11)
For more information about this report visit http://www.researchandmarkets.com/research/hcn98g/next_generation
